Market Overview:
The India generic injectables market reached a value of US$ 2.1 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 4.4 Billion by 2027, exhibiting a CAGR of 12.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.
Generic injectables refer to alternative drugs that are bio-equivalent of their branded counterparts in terms of active ingredients, strength, quality, effectiveness, intended use, and dosage. They are used to treat various life-threatening and chronic diseases, such as cancer, diabetes, rheumatoid arthritis, cardiovascular ailments, and respiratory infections. As compared to innovator drugs, generic injectables offer maximized patient compliance, reduced frequency of drug delivery, limited price erosion, and higher profitability for manufacturers.
The increasing prevalence of chronic diseases in India, due to the rising pollution levels and unhealthy lifestyle of the population are the major factors driving the generic injectables market growth. This, in turn, has led to a rise in the expenditure on innovation in generic injectables for effective drug administration and faster recovery of patients. Additionally, an expansion in the life science industry and rapid technological advancements in drug delivery systems, such as the development of self-injection devices, are contributing to the market growth. Moreover, rising economic development in India has resulted in improved healthcare facilities, which is acting as another growth-inducing factor. Apart from this, the increasing shortage of branded medicines and expiry of patents of branded items, are further creating a positive outlook for the market in the country.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the India generic injectables market, along with forecasts at the country and regional level from 2022-2027. Our report has categorized the market based on therapeutic area, container and distribution channel.
Breakup by Therapeutic Area:
- Oncology
- Anaesthesia
- Anti-infectives
- Parenteral Nutrition
- Cardiovascular
Breakup by Container:
- Vials
- Ampoules
- Premix
- Prefilled Syringes
Breakup by Distribution Channel:
- Hospitals
- Retail Pharmacy
Breakup by Region:
- North India
- West and Central India
- South India
- East India
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Therapeutic Area, Container, Distribution Channel, Region |
| Region Covered |
North India, West and Central India, South India, East India |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 2999
Corporate License: US$ 3499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the India generic injectables market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the India generic injectables market?
- What are the key regional markets?
- What is the breakup of the market based on the therapeutic area?
- What is the breakup of the market based on the container?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the India generic injectables market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 India Generic Injectables Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Therapeutic Area
6.1 Oncology
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Anaesthesia
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Anti-infectives
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Parenteral Nutrition
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Cardiovascular
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Container
7.1 Vials
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Ampoules
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Premix
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Prefilled Syringes
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
9 Market Breakup by Region
9.1 North India
9.1.1 Market Trends
9.1.2 Market Breakup by State
9.1.3 Market Forecast
9.2 West and Central India
9.2.1 Market Trends
9.2.2 Market Breakup by State
9.2.3 Market Forecast
9.3 South India
9.3.1 Market Trends
9.3.2 Market Breakup by State
9.3.3 Market Forecast
9.4 East India
9.4.1 Market Trends
9.4.2 Market Breakup by State
9.4.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Policy and Regulatory Landscape
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
List of Figures
Figure 1: India: Generic Injectables Market: Major Drivers and Challenges
Figure 2: India: Generic Injectables Market: Sales Value (in Billion US$), 2016-2021
Figure 3: India: Generic Injectables Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: India: Generic Injectables Market: Breakup by Therapeutic Area (in %), 2021
Figure 5: India: Generic Injectables Market: Breakup by Container (in %), 2021
Figure 6: India: Generic Injectables Market: Breakup by Distribution Channel (in %), 2021
Figure 7: India: Generic Injectables Market: Breakup by Region (in %), 2021
Figure 8: India: Generic Injectables (Oncology) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: India: Generic Injectables (Oncology) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: India: Generic Injectables (Anaesthesia) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: India: Generic Injectables (Anaesthesia) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: India: Generic Injectables (Anti-infectives) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: India: Generic Injectables (Anti-infectives) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: India: Generic Injectables (Parenteral Nutrition) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: India: Generic Injectables (Parenteral Nutrition) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: India: Generic Injectables (Cardiovascular) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: India: Generic Injectables (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: India: Generic Injectables (Vials) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: India: Generic Injectables (Vials) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: India: Generic Injectables (Ampoules) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: India: Generic Injectables (Ampoules) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: India: Generic Injectables (Premix) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: India: Generic Injectables (Premix) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: India: Generic Injectables (Prefilled Syringes) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: India: Generic Injectables (Prefilled Syringes) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: India: Generic Injectables (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: India: Generic Injectables (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: India: Generic Injectables (Retail Pharmacy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: India: Generic Injectables (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North India: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North India: Generic Injectables Market: Breakup by State (in %), 2021
Figure 32: North India: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 33: West and Central India: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 34: West and Central India: Generic Injectables Market: Breakup by State (in %), 2021
Figure 35: West and Central India: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: South India: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: South India: Generic Injectables Market: Breakup by State (in %), 2021
Figure 38: South India: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 39: East India: Generic Injectables Market: Sales Value (in Million US$), 2016 & 2021
Figure 40: East India: Generic Injectables Market: Breakup by State (in %), 2021
Figure 41: East India: Generic Injectables Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Generic Injectables Industry: SWOT Analysis
Figure 43: India: Generic Injectables Industry: Value Chain Analysis
Figure 44: India: Generic Injectables Industry: Porter’s Five Forces Analysis
List of Tables
Table 1: India: Generic Injectables Market: Key Industry Highlights, 2021 and 2027
Table 2: India: Generic Injectables Market Forecast: Breakup by Therapeutic Area (in Million US$), 2022-2027
Table 3: India: Generic Injectables Market Forecast: Breakup by Container (in Million US$), 2022-2027
Table 4: India: Generic Injectables Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: India: Generic Injectables Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: India: Generic Injectables Market: Competitive Structure
Table 7: India: Generic Injectables Market: Key Players